GlassScriptPhysician profile
Mark Ganjianpour
NPI 1447229570
$3,565.57
in general payments reported to CMS, 2019-2025
12 companies · $77.34 in 2025
The $77.34 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $96.61 · 2021: $181 · 2022: $2,638 · 2023: $166 · 2024: $35.56 · 2025: $77.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $1,691.25 | 2022 | |
| Medacta USA, INC. | $947.06 | 2022 | |
| Stryker Corporation | $331.63 | 2019-2025 | Mako, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $129.21 | 2019-2025 | Gps III Platelet Concentration System, Juggerknotless Soft Anchor, Quattro |
| Micromed INC | $122.11 | 2021 | |
| Medtronic USA, INC. | $93.09 | 2019 | |
| Ermi LLC | $84.86 | 2019-2020 | |
| Horizon Therapeutics Plc | $63.74 | 2020-2021 | |
| Djo, LLC | $40.75 | 2024-2025 | Procare, Donjoy |
| Vericel Corporation | $29.10 | 2020 | |
| Orthofix Medical, INC. | $17.76 | 2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $15.01 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ganjianpour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.